BACH1, which we recently identified as an inhibitor of mitochondrial metabolism that can be targeted independently in ~30% of breast tumors (Lee et al., 2019), is shown here to be a transcriptionally-regulated and pro-invasive mediator of the stress MAPK network. This evidence concerns the gene BACH1 and breast neoplasm.